A Closed Signal, within the context of periodic benefit-risk evaluation reports, refers to a signal that has undergone a complete evaluation and analysis within the reporting interval specified in the report. This evaluation typically involves a comprehensive assessment of the available data related to the signal, including any new information or emerging evidence. Closed signals are those for which the assessment has been finalized, and the report may include the conclusions and actions taken based on the results of the evaluation.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management